Abstract:Long non‑coding RNAs (lncRNAs) serve important roles in the tumorigenesis of a diverse range of cancer types. The lung cancer‑associated transcript 1 (LUCAT1), has been reported to promote the proliferation, migration and invasion of oral squamous cell carcinoma cells. However, the exact role of LUCAT1 in laryngeal squamous cell carcinoma (LSCC) remains to fully understood. The present study aimed to interrogate the role and modulatory mechanism of LUCAT1 in LSCC. Reverse transcription‑quantitative PCR and western blotting were used to investigate the expression of LUCAT1 and miR‑493, as well as the protein expression of cyclin‑dependent kinase 2, cyclin E1, p21, matrix metalloproteinase (MMP)2, MMP9, vascular endothelial growth factor‑C, Bcl‑2, Bax, cleaved caspase‑3 and procaspase‑3. Cell Counting Kit‑8, flow cytometry, wound healing and Transwell assays were performed to analyze the proliferation, cell cycle, apoptosis levels, and the migratory and invasive abilities, respectively, of the LSCC AMC‑HN‑8 cell line. In addition, dual‑luciferase reporter and ribonucleoprotein immunoprecipitation assays were used to investigate the binding between LUCAT1 and microRNA (miR)‑493. The results of the present study revealed that the expression levels of LUCAT1 were upregulated in AMC‑HN‑8 cells. The genetic knockdown of LUCAT1 expression levels significantly suppressed the cell proliferation, alongside downregulating the expression levels of CDK2 and cyclin E1 and upregulating p21 expression levels. In addition, the knockdown of LUCAT1 inhibited cell migration and invasion, as demonstrated using the wound healing and Transwell assays, respectively. Moreover, LUCAT1 knockdown promoted cell apoptosis and upregulated the expression levels of Bax and cleaved caspase‑3, whilst downregulating the expression levels of Bcl‑2. Furthermore, LUCAT1 was discovered to directly bind to and inhibit the well‑known tumor suppressor, miR‑493. Notably, the specific inhibition of miR‑493 partly blocked the anticancer effects of LUCAT1 knockdown in AMC‑HN‑8 cells. In conclusion, these results suggested that LUCAT1 may facilitate tumorigenesis in LSCC through the targeted inhibition of miR‑493, which provides evidence for a novel target for the treatment of LSCC.

MicroRNA-195 Inhibits Growth and Invasion of Laryngeal Carcinoma Cells by Directly Targeting DCUN1D1.

MicroRNA-145 Inhibits Growth of Laryngeal Squamous Cell Carcinoma by Targeting the PI3K/Akt Signaling Pathway.

Long Noncoding RNA UCA1 Promotes Cell Growth, Migration, and Invasion by Targeting Mir‐143‐3p in Oral Squamous Cell Carcinoma

MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.

MicroRNA‑195 is Associated with Regulating the Pathophysiologic Process of Human Laryngeal Squamous Cell Carcinoma.

MiR-205 suppressed the malignant behaviors of breast cancer cells by targeting CLDN11 via modulation of the epithelial-to-mesenchymal transition

MicroRNA-195-5p Suppresses the Proliferation, Migration, Invasion and Epithelial-Mesenchymal Transition of Laryngeal Cancer Cells in Vitro by Targeting E2F3

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

MicroRNA-195 Inhibits Proliferation and Metastasis in Renal Cell Carcinoma Via Regulating HMGA1.

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

Differential Expression of Mir-195 in Esophageal Squamous Cell Carcinoma and Mir-195 Expression Inhibits Tumor Cell Proliferation and Invasion by Targeting of Cdc42.

Mir-203 is Involved in the Laryngeal Carcinoma Pathogenesis Via Targeting VEGFA and Cox-2.

MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.

Prognostic Implications of Micorna Mir-195 Expression in Human Tongue Squamous Cell Carcinoma.

MiR-196b Affects the Progression and Prognosis of Human LSCC Through Targeting PCDH-17

Mir-139 Targets CXCR4 and Inhibits the Proliferation and Metastasis of Laryngeal Squamous Carcinoma Cells

MicroRNA-203 Inhibits Invasion and Induces Apoptosis of Laryngeal Cancer Cells Via Targeting LASP1.

LINC01783 Accelerated Tongue Squamous Cell Carcinoma Progression Via Inhibiting Mir‐199b‐5p

MiR-5189-3p Suppresses cell Proliferation, Invasion and Migration Through Targeting EIF5A2 in Laryngeal Squamous Cell Carcinoma

Circ_0000218 Plays a Carcinogenic Role in Laryngeal Cancer Through Regulating Microrna-139-3p/smad3 Axis.

Lung cancer‐associated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR‐493